Ionis Pharmaceuticals (IONS) Enterprise Value (2009 - 2026)
Ionis Pharmaceuticals (IONS) posted quarterly Enterprise Value of -$2.1 billion for Q2 2026, up 10.28% year-over-year from -$1.9 billion in Q2 2025, and down 7.06% quarter-over-quarter from -$1.9 billion in Q1 2026.
Ionis Pharmaceuticals (IONS) Enterprise Value (2009 - 2026) Analysis & Trends
Ionis Pharmaceuticals' Enterprise Value history runs 18 years deep, the most recent figure standing at -$2.1 billion for Q2 2026.
- In Q2 2026, Enterprise Value rose 10.28% year-over-year to -$2.1 billion; the TTM figure through Jun 2026 stood at -$2.1 billion (up 10.28% YoY), while the FY2025 annual figure was -$2.7 billion, down 16.53% from the prior year.
- Enterprise Value for Q2 2026 stood at -$2.1 billion, down from -$1.9 billion in the prior quarter.
- The five-year high for Enterprise Value was -$1.9 billion in Q1 2026, with the low at -$2.7 billion in Q4 2025.
- The 5-year median for Enterprise Value is -$2.2 billion (2023), against an average of -$2.2 billion.
- The sharpest annual moves came in 2023 and 2024: Enterprise Value declined 17.98% in 2023, then advanced 12.86% in 2024.
- Ionis Pharmaceuticals' Enterprise Value stood at -$2.0 billion in 2022, then decreased by 17.33% to -$2.3 billion in 2023, then gained by 1.44% to -$2.3 billion in 2024, then declined by 16.53% to -$2.7 billion in 2025, then gained by 23.26% to -$2.1 billion in 2026.
- Business Quant data shows IONS's Enterprise Value at -$2.1 billion in Q2 2026, -$1.9 billion in Q1 2026, and -$2.7 billion in Q4 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Enterprise Value (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | -7.85 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | -7.99 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | -5.18 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | -3.94 Bn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | -5.10 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | -8.46 Mn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 2.12 Bn |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | -3.31 Bn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | -1.16 Bn |
| 10 | Ionis Pharmaceuticals | 9.48 Bn | 7.43 Bn | 265.21 Mn | -2.05 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -2.05 Bn |
| Mar 31, 2026 | -1.92 Bn |
| Dec 31, 2025 | -2.68 Bn |
| Sep 30, 2025 | -2.24 Bn |
| Jun 30, 2025 | -2.29 Bn |
| Mar 31, 2025 | -2.15 Bn |
| Dec 31, 2024 | -2.30 Bn |
| Sep 30, 2024 | -2.48 Bn |
| Jun 30, 2024 | -2.08 Bn |
| Mar 31, 2024 | -2.21 Bn |
| Dec 31, 2023 | -2.33 Bn |
| Sep 30, 2023 | -2.24 Bn |
| Jun 30, 2023 | -2.39 Bn |
| Mar 31, 2023 | -2.35 Bn |
| Dec 31, 2022 | -1.99 Bn |
| Sep 30, 2022 | -1.98 Bn |
| Jun 30, 2022 | -2.02 Bn |
| Mar 31, 2022 | -2.05 Bn |
| Dec 31, 2021 | -2.11 Bn |
| Sep 30, 2021 | -1.99 Bn |